NEOS Investment Management LLC Has $107.21 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

NEOS Investment Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.2% in the 2nd quarter, HoldingsChannel reports. The firm owned 269,580 shares of the medical equipment provider’s stock after acquiring an additional 25,047 shares during the quarter. NEOS Investment Management LLC’s holdings in Intuitive Surgical were worth $107,207,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Motiv8 Investments LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $34,000. Main Street Group LTD acquired a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $39,000. Vermillion Wealth Management Inc. increased its position in shares of Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares in the last quarter. Finally, High Note Wealth LLC raised its holdings in shares of Intuitive Surgical by 50.0% during the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 23 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, Director Amy Ladd sold 72 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director directly owned 179 shares in the company, valued at $70,364.90. The trade was a 28.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. This trade represents a 8.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 11,658 shares of company stock worth $4,649,835. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $369.83 on Friday. The stock has a market cap of $130.65 billion, a P/E ratio of 42.36, a P/E/G ratio of 2.81 and a beta of 1.47. The firm has a 50 day simple moving average of $382.20 and a 200 day simple moving average of $429.04. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.81 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ISRG shares. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Citigroup reduced their target price on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Bank of America decreased their target price on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.